FI20031455A0 - Sulfonylamino-peptidomimeter som är aktiva i förhållande till somatostatinreceptorsubtyper 4(SSTR4) och 1(SSTR1) - Google Patents

Sulfonylamino-peptidomimeter som är aktiva i förhållande till somatostatinreceptorsubtyper 4(SSTR4) och 1(SSTR1)

Info

Publication number
FI20031455A0
FI20031455A0 FI20031455A FI20031455A FI20031455A0 FI 20031455 A0 FI20031455 A0 FI 20031455A0 FI 20031455 A FI20031455 A FI 20031455A FI 20031455 A FI20031455 A FI 20031455A FI 20031455 A0 FI20031455 A0 FI 20031455A0
Authority
FI
Finland
Prior art keywords
sstr4
sstr1
somatostatin receptor
peptidomimetics
sulfonylamino
Prior art date
Application number
FI20031455A
Other languages
English (en)
Finnish (fi)
Inventor
Jussi Tomperi
Mia Engstroem
Siegfried Wurster
Original Assignee
Juvantia Pharma Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juvantia Pharma Ltd Oy filed Critical Juvantia Pharma Ltd Oy
Priority to FI20031455A priority Critical patent/FI20031455A0/sv
Publication of FI20031455A0 publication Critical patent/FI20031455A0/sv
Priority to US10/574,905 priority patent/US20070129313A1/en
Priority to JP2006530316A priority patent/JP2007507472A/ja
Priority to EP04767097A priority patent/EP1678196B1/en
Priority to AT04767097T priority patent/ATE404580T1/de
Priority to PCT/FI2004/000583 priority patent/WO2005033124A1/en
Priority to DE602004015822T priority patent/DE602004015822D1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • C07K5/06095Arg-amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI20031455A 2003-10-06 2003-10-06 Sulfonylamino-peptidomimeter som är aktiva i förhållande till somatostatinreceptorsubtyper 4(SSTR4) och 1(SSTR1) FI20031455A0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20031455A FI20031455A0 (sv) 2003-10-06 2003-10-06 Sulfonylamino-peptidomimeter som är aktiva i förhållande till somatostatinreceptorsubtyper 4(SSTR4) och 1(SSTR1)
US10/574,905 US20070129313A1 (en) 2003-10-06 2004-10-05 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1)
JP2006530316A JP2007507472A (ja) 2003-10-06 2004-10-05 ソマトスタチン受容体サブタイプ4(sstr4)及び1(sstr1)に作用するスルホニルアミノ−ペプチド模倣薬
EP04767097A EP1678196B1 (en) 2003-10-06 2004-10-05 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1)
AT04767097T ATE404580T1 (de) 2003-10-06 2004-10-05 Sulfonylamino-peptidomimetika, die auf die somatostatinrezeptor-subtypen 4 (sstr4) und 1 (sstr1) wirken
PCT/FI2004/000583 WO2005033124A1 (en) 2003-10-06 2004-10-05 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1)
DE602004015822T DE602004015822D1 (de) 2003-10-06 2004-10-05 Sulfonylamino-peptidomimetika, die auf die somatostatinrezeptor-subtypen 4 (sstr4) und 1 (sstr1) wirken

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20031455A FI20031455A0 (sv) 2003-10-06 2003-10-06 Sulfonylamino-peptidomimeter som är aktiva i förhållande till somatostatinreceptorsubtyper 4(SSTR4) och 1(SSTR1)

Publications (1)

Publication Number Publication Date
FI20031455A0 true FI20031455A0 (sv) 2003-10-06

Family

ID=29225904

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20031455A FI20031455A0 (sv) 2003-10-06 2003-10-06 Sulfonylamino-peptidomimeter som är aktiva i förhållande till somatostatinreceptorsubtyper 4(SSTR4) och 1(SSTR1)

Country Status (6)

Country Link
US (1) US20070129313A1 (sv)
EP (1) EP1678196B1 (sv)
JP (1) JP2007507472A (sv)
AT (1) ATE404580T1 (sv)
FI (1) FI20031455A0 (sv)
WO (1) WO2005033124A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20031454A0 (sv) * 2003-10-06 2003-10-06 Juvantia Pharma Ltd Oy Selektiva somatostatinreceptor 1 och/eller 4 -agonister och -antagonister
US20100004339A1 (en) * 2003-10-06 2010-01-07 Oy Juvantia Pharma Ltd. Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists
WO2005082845A1 (en) * 2004-02-27 2005-09-09 Oy Juvantia Pharma Ltd Novel therapies with somatostatin receptor agonists
WO2005082844A1 (en) * 2004-02-27 2005-09-09 Oy Juvantia Pharma Ltd Treatment of diseases by using a somatostatin receptor agonist
CA2609161A1 (en) * 2005-05-18 2006-11-23 Siegfried Wurster Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
JP7343170B2 (ja) 2017-05-12 2023-09-12 ボード オブ トラスティーズ オブ ザ サザン イリノイ ユニバーシティ オン ビハーフ オブ サザン イリノイ ユニバーシティ エドワーズビル 3,4,5-三置換-1,2,4-トリアゾールおよび3,4,5-三置換-3-チオ-1,2,4-トリアゾール、ならびにそれらの使用
US11912687B2 (en) 2017-05-12 2024-02-27 Board of Trustees of the Southern Illinois University 3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof
JP7099717B2 (ja) * 2019-09-30 2022-07-12 株式会社理研バイオ ソマトスタチン受容体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2447314A1 (en) * 2001-05-15 2002-11-21 Atsuro Nakazato Arginine derivatives
WO2003026575A2 (en) * 2001-09-24 2003-04-03 Synaptic Pharmaceutical Corporation Molecules specific for npff receptors and uses thereof
WO2003026657A1 (en) * 2001-09-24 2003-04-03 Synaptic Pharmaceutical Corporation Compounds for the treatment of pain
JP2004155695A (ja) * 2002-11-06 2004-06-03 Taisho Pharmaceut Co Ltd Mc4受容体に対するリガンド
FI20031454A0 (sv) * 2003-10-06 2003-10-06 Juvantia Pharma Ltd Oy Selektiva somatostatinreceptor 1 och/eller 4 -agonister och -antagonister

Also Published As

Publication number Publication date
EP1678196A1 (en) 2006-07-12
JP2007507472A (ja) 2007-03-29
EP1678196B1 (en) 2008-08-13
WO2005033124A1 (en) 2005-04-14
ATE404580T1 (de) 2008-08-15
US20070129313A1 (en) 2007-06-07

Similar Documents

Publication Publication Date Title
DK1337518T3 (da) Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
BR0306150A (pt) Composto, uso de um composto, e, composição farmacêutica
EA200301073A1 (ru) N-(2-арилэтил)бензиламины в качестве антагонистов 5-ht-рецептора
NO20060154L (no) Imidazolyl-derivater
TW200637550A (en) Thiazole-4-carboxamide derivatives as mGluR5 antagonists
AU2006243987A8 (en) Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof
ATE396993T1 (de) Tetrahydropyranyl-cyclopentyl- tetrahydropyridopyridin-modulatoren der chemokin- rezeptor-aktivität
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
DE602004012858D1 (de) 2-aminobenzothiazole als cb1 rezeptor inverse agonisten
SG163585A1 (en) Melanocortin receptor ligands
MXPA06012595A (es) Analogos de amino-tetrazoles y metodos de uso.
EA200700365A1 (ru) Производные индол-2-карбоксамидина как антагонисты nmda рецептора
WO2002010140A3 (en) Imidazolyl derivatives
BRPI0516602A (pt) composto, e, composição farmacêutica
TW200800982A (en) Pyrazolopyridine derivatives as inhibitors of β-adrenergic receptor kinase 1
FI20031455A0 (sv) Sulfonylamino-peptidomimeter som är aktiva i förhållande till somatostatinreceptorsubtyper 4(SSTR4) och 1(SSTR1)
ATE411287T1 (de) Neue metallproteinaseinhibitoren
ATE393781T1 (de) Somatostatin analoge, deren radiomarkierte derivate und deren verwendung
MXPA05013149A (es) Derivados de imidazol como antagonistas del receptor de glutamato.
EA200801549A1 (ru) Новые производные фенантридина в качестве антагонистов брадикинина
DK1644389T3 (da) Pyrinidinforbindelser med phosphonatgrupper som antivirale nukleotidanaloger
NO20084698L (no) Metode for fremstilling av indazolyl-ureaer som inhiberer vanilloidreseptor subtype 1(VR1)
FI20031454A0 (sv) Selektiva somatostatinreceptor 1 och/eller 4 -agonister och -antagonister
DE60139770D1 (de) Hydantoin derivate mit affinität für somatostatin rezeptoren
DE60319989D1 (de) Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande

Legal Events

Date Code Title Description
FD Application lapsed